Back to Savant Capital, LLC Savant Capital, LLC

ADPTADPT
Showing 8 of 12 quarters

Position history for Savant Capital, LLCSavant Capital, LLC's holdings in Adaptive Biotechnologies Corp.

Savant Capital, LLC previously held 0 shares of ADPT (Adaptive Biotechnologies Corp.), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$175,207

Total Shares Change

-34,220

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$21.45
0
2026-Q1
Increased
16,651
+0.9%
$231,1160.0%$16.08
23
2025-Q4
Increased
16,497
+0.0%
$267,9120.0%$16.42
23
2025-Q3
Unchanged
16,493
0.0%
$246,7360.0%$13.46
0
2025-Q2
Unchanged
16,493
0.0%
$192,1440.0%$11.79
0
2025-Q1
Decreased
16,493
-51.8%
$122,5430.0%$7.67
0
2024-Q4
Increased
34,221
0.0%
$205,1550.0%$6.11
23
2024-Q3
Unchanged
34,220
0.0%
$175,2070.0%$5.00
0

Other major holders of ADPT: VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used